Clinical Trials Directory

Trials / Terminated

TerminatedNCT00326196

Coronary Artery Revascularization in Diabetes

CSP #557 - Coronary Artery Revascularization in Diabetes (VA CARDS)

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
198 (actual)
Sponsor
US Department of Veterans Affairs · Federal
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, multi-site, clinical trial comparing percutaneous coronary stenting (PCI) with drug eluding stents to coronary bypass for angiographically significant coronary artery disease in diabetes. The hypothesis being tested is that a strategy of surgical revascularization is superior to percutaneous intervention in preventing death or myocardial infarction in diabetics with severe ischemic heart disease.

Detailed description

Diabetic patients (HbA1c greater than 6.0% if treated or greater than 6.9% untreated) with severe ischemic heart disease and clinical indications for coronary revascularization will be screened and, if agreeable, entered into the study. Qualified patients unwilling to participate in the randomized trial will be approached for participation in a Registry that will collect computerized health data. The study consists of a 4-year accrual period. The median follow-up will be 3.7 years with a maximum of six years and a minimum of two years. Six sites will begin recruitment in the first year followed by nine additional sites for the remaining three years. The study is powered to detect a 40% relative difference between the groups in time to death or MI with a two-sided, type I error of 5% and a power of 90%.

Conditions

Interventions

TypeNameDescription
DEVICEPercutaneous coronary intervention (PCI)percutaneous coronary stenting with drug eluding stents
PROCEDURECoronary artery bypass graft (CABG)coronary bypass

Timeline

Start date
2006-07-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2006-05-16
Last updated
2014-04-25
Results posted
2014-02-06

Locations

26 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00326196. Inclusion in this directory is not an endorsement.